John MikitshEngineer, Process and Product Development at Century Therapeutics, LLC
John Mikitsh has been working in the CGT space for the past 5 years. A biochemist and chemical engineer by training, his background primarily involves early stage process development and technology transfer. After leading development of suspension lentivirus and adeno-associated virus platforms at WuXi Advanced Therapies, he joined Century Therapeutics in 2019. John now leads a small team in the process and product development group. The team is responsible for scaling up iPSC derived manufacturing processes, design of Century’s GMP processing space, and tech transfer.